January 29, 2025 – The International Society for Cell & Gene Therapy (ISCT) is delighted to announce the appointment of Phil Vanek, PhD, as the new ISCT Chief Commercialization Officer (CCO), effective January 1, 2025, through December 31, 2026. Dr. Vanek is an internationally...
VANCOUVER, British Columbia, December 20, 2024 - The International Society for Cell & Gene Therapy (ISCT) celebrates the US Food and Drug Administration’s (FDA) landmark decision to approve Mesoblast Limited’s allogenic, bone marrow-derived mesenchymal stromal cell (MSC) product,...
October 3 rd , 2024 – The International Society for Cell & Gene Therapy (ISCT) celebrates a major legal victory in the ongoing fight to protect the public from unregulated cell and gene therapies. In U.S. v. California Stem Cell Treatment Center, Inc., the U.S. Court of Appeals for...
The International Society for Cell & Gene Therapy (ISCT) celebrates the recent announcement of the U.S. Food and Drug Administration's (FDA) accelerated approval of Tecelra (afamitresgene autoleucel) for the treatment of adults with unresectable or metastatic synovial sarcoma who have...
The Rise of Asia Pacific: Learning From the Region’s Leaders and Innovators Organized by: ISCT Asia Regional Executive Committee Summary of Key Points from ISCT 2024 Vancouver Roundtable session on May 31, 8 am Moderator: Steve Oh, PhD - Independent Cell Therapy Leader, Singapore ...
Are you using prediction algorithms, machine learning (ML), or artificial intelligence (AI) in your work? Are you interested in finding out more about these terms and their applications? As part of a two-part initiative on AI and ML, The ISCT Process Development & Manufacturing Sub...
Wouter Van’t Hof, Contributing Editor Cleveland Cord Blood Center Cleveland OH, USA What’s in Your CGT Product? The shared responsibility of all of us cell and gene therapy developers involved with ISCT and with the ambition of bringing cell-based therapies to...
Vancouver, Canada, January 09, 2024 - The International Society for Cell & Gene Therapy (ISCT), the global society of clinicians, researchers, regulators, technologists, and industry partners dedicated to the translation of cell and gene therapy (CGT) into safe and effective...
ISCT Asia Regional Early Stage Professionals (ESP) Subcommittee Expanding the collaboration network to promote our clinical translation and successful services of cell and gene therapies Sudipto Bari, PhD 1 , Chaiyong Koaykul, PhD 2 Co-chairs ISCT Asia regional ESP...
ISCT issues response to US federal judge ruling on FDA regulation of cell and gene therapies US federal judge ruling of significant concern, with widespread implications for cell and gene therapy sector as well as patient safety Vancouver, Canada, September 12, 2022 - ...